Scientists have developed a new preparation method that renders a virus or bacterium non-infectious while preserving its immune-boosting ability after exposure to gamma radiation. A lethally irradiated vaccine was successfully tested in mice against drug-resistant Staphylococcus aureus (MRSA) bacteria and holds promise for other such deadly diseases.

Share This

The scientists used the Mn-peptide complex in a laboratory setting to successfully protect from radiation damage the protein epitopes of Venezuelan equine encephalitis virus, a microbe that causes a mosquito- borne disease of the nervous system. They also used the preparation method to develop an effective vaccine against methicillin-resistant S. aureus (MRSA) infections in mice.

Scientists from the Uniformed Services University of the Health Sciences (USU) have developed a new preparation method that renders a virus or bacterium non-infectious while preserving its immune-boosting ability after exposure to gamma radiation. A vaccine exposed to megadoses of gamma radiation was successfully tested in mice against drug-resistant Staphylococcus aureus bacteria by colleagues at the National Institutes of Health (NIH), and holds promise for other such deadly diseases.

Related Articles

The results of the breakthrough study were published in the July edition of Cell Host and Microbe.

High doses of radiation typically destroy a pathogen's genome, rendering it unable to cause infection when used in a vaccine. However, radiation also damages a microbe's protein epitopes, which the immune system must recognize for a vaccine to be protective. Organisms inactivated, or killed, by radiation trigger better immune responses than those inactivated by traditional heat or chemical methods. Although live vaccines may provide better immune protection than irradiated vaccines, live vaccines are frequently not an option as they can carry an unacceptable risk of infection with an otherwise untreatable disease (e.g., HIV). Lethally irradiated vaccines could also help the developing world, where the need for cold storage limits the availability of live vaccines.

To separate genome destruction from epitope survival, the researchers borrowed some complex chemistry from the world's toughest bacterium Deinococcus radiodurans, nicknamed "Conan the Bacterium," which can withstand 3,000 times the radiation levels that would kill a human being. In 2000, Deinococcus was engineered for cleanup of highly radioactive wastes left over from the production of atomic bombs. Now, unusual Mn(II)-antioxidants discovered in this extremophile have been successfully applied to preparing irradiated vaccines.

Deinococcus accumulates high concentrations of manganese and peptides, which the scientists combined in the laboratory -- forming a potent antioxidant complex which specifically protects proteins from radiation. They found that the complex preserves immune-related epitopes when applied to viruses and bacteria during exposure to gamma radiation, but did not protect their genomes.

Michael J. Daly, Ph.D., professor of Pathology at USU, and his research team, collaborated on the work with Sandip K. Datta, M.D., and colleagues at NIH's National Institute of Allergy and Infectious Diseases (NIAID). Daly devoted 20 years to studying Deinococcus radiodurans, which has led to three patents for his work.

The scientists used the Mn-peptide complex in a laboratory setting to successfully protect from radiation damage the protein epitopes of Venezuelan equine encephalitis virus, a microbe that causes a mosquito- borne disease of the nervous system. They also used the preparation method to develop an effective vaccine against methicillin-resistant S. aureus (MRSA) infections in mice.

Learning to Care for Those in Harm's Way

The researchers believe the whole-microbe vaccine approach could extend to any infectious organism that can be cultivated, whether fungi, parasites, protozoa, viruses or bacteria -- including agents that mutate rapidly, such as pandemic influenza and HIV. The groups aim to demonstrate this method of irradiation as a rapid, cost-effective approach to vaccine development.

The project was funded by the Air Force Office of Scientific Research (AFOSR) and the intramural research program of the NIAID.

More From ScienceDaily

More Health & Medicine News

Featured Research

Mar. 3, 2015 — New assays can detect malaria parasites in human blood at very low levels and might be helpful in the campaign to eradicate malaria, reports a new study. An international team led by Ingrid Felger, ... full story

Mar. 3, 2015 — Adults over the age of 30 only catch flu about twice a decade, a new study suggests. So, while it may feel like more, flu-like illness can be caused by many pathogens, making it difficult to assess ... full story

Mar. 3, 2015 — No significant change in home habits of smokers have been observed in the aftermath of a ban on smoking in public spaces, researchers report. Greater inspiration to kick the habit likely comes from ... full story

Mar. 3, 2015 — Heart function has been associated with the development of dementia and Alzheimer's disease through a new study. Participants with decreased heart function, measured by cardiac index, were two to ... full story

Mar. 3, 2015 — Children of recently separated or divorced families are likelier to drink sugar-sweetened beverages than children in families where the parents are married, putting them at higher risk for obesity ... full story

Mar. 3, 2015 — Gastric bypass and similar stomach-shrinking surgeries are a popular option for obese patients looking to lose weight or treat type 2 diabetes. While the surgeries have been linked to a decreased ... full story

Mar. 3, 2015 — Most people consume more salt than they need and therefore have a higher risk of heart disease and stroke, which are the two leading causes of death worldwide. But a new study reveals that dietary ... full story

Mar. 3, 2015 — Twice as many children born to mothers who took antibiotics during pregnancy were diagnosed with asthma by age 3 than children born to mothers who didn’t take prenatal antibiotics, a new study has ... full story

Mar. 3, 2015 — Although sedatives are often administered before surgery, a randomized trial finds that among patients undergoing elective surgery under general anesthesia, receiving the sedative lorazepam before ... full story

Featured Videos

Mom Triumphs Over Tragedy, Helps Other Families

AP (Mar. 3, 2015) — After her son, Dax, died from a rare form of leukemia, Julie Locke decided to give back to the doctors at St. Jude Children&apos;s Research Hospital who tried to save his life. She raised $1.6M to help other patients and their families. (March 3)
Video provided by AP

Looted and Leaking, South Sudan's Oil Wells Pose Health Risk

AFP (Mar. 3, 2015) — Thick black puddles and a looted, leaking ruin are all that remain of the Thar Jath oil treatment facility, once a crucial part of South Sudan&apos;s mainstay industry. Duration: 01:13
Video provided by AFP

Woman Convicted of Poisoning Son

AP (Mar. 3, 2015) — A woman who blogged for years about her son&apos;s constant health woes was convicted Monday of poisoning him to death by force-feeding heavy concentrations of sodium through his stomach tube. (March 3)
Video provided by AP

Related Stories

Dec. 8, 2014 — A new investigational vaccine, NDV-3, employing the recombinant protein Als3, can mobilize the immune system to fight off MRSA skin infections in an experimental model, researchers have ... full story

Aug. 19, 2014 — A variant of the century-old vaccine Bacille Calmette-Guerin is superior to BCG in protecting against tuberculosis in animal models, and also cross protects against leprosy, researchers report. ... full story

Aug. 1, 2013 — Deletion of a protein in white blood cells improves their ability to fight the bacteria staphylococcus aureus and possibly other infections in mice with chronic granulomatous disease (CGD), according ... full story

May 22, 2013 — A new approach for immunizing against influenza elicited a more potent immune response and broader protection than the currently licensed seasonal influenza vaccines when tested in mice and ferrets. ... full story

Feb. 18, 2011 — Researchers in Belgium have improved the efficacy of the vaccine for tuberculosis. The new vaccine affords, as already demonstrated in mice, better protection against the disease. The development of ... full story

ScienceDaily features breaking news and videos about the latest discoveries in health, technology, the environment, and more -- from major news services and leading universities, scientific journals, and research organizations.